Table 3.
Variables | Sp + Dev (n = 45) | BRTO (n = 55) | p value |
---|---|---|---|
Therapeutic effect after procedure (n, %) | |||
Improvement of endoscopic findings for gastric varices | 38(84.4) | 51(92.7) | 0.188 |
Complications (n, %) | |||
Ascites | 22 (48.9) | 3 (5.5) | <0.001 |
Portal vein thrombosis | 7 (15.6) | 2 (3.6) | 0.038 |
Splenic vein thrombosis | 1 (2.2) | 0 (0.0) | 0.267 |
Esophageal varices bleeding | 1 (2.2) | 1 (1.8) | 0.886 |
Infection except SSI | 5 (11.1) | 4 (7.3) | 0.505 |
SSI | 9 (20.0) | – | – |
Postoperative bleeding | 1 (2.2) | – | – |
Pancreatic fistula | 1 (2.2) | – | – |
Mortality in hospital stay | 0 (0.0) | 1 (1.8) | 0.363 |
Hospital stay (days) | 17.8 | 10.5 | 0.003 |
Sp + Dev splenectomy and gastric devascularization, BRTO balloon-occluded transvenous obliteration, SSI surgical site infection